Provided by Tiger Fintech (Singapore) Pte. Ltd.

Astria Therapeutics Inc

5.57
+0.13002.39%
Post-market: 5.570.00000.00%19:30 EDT
Volume:1.35M
Turnover:7.54M
Market Cap:314.34M
PE:-2.97
High:5.64
Open:5.44
Low:5.41
Close:5.44
Loading ...

Analysts Are Bullish on Top Healthcare Stocks: Vericel (VCEL), Astria Therapeutics (ATXS)

TIPRANKS
·
28 Feb

Astria Therapeutics Initiates Alpha-Orbit Phase 3 Pivotal Trial of Navenibart in Hereditary Angioedema

THOMSON REUTERS
·
27 Feb

Astria Therapeutics Initiates ALPHA-ORBIT Phase 3 Pivotal Trial of Navenibart in Hereditary Angioedema

Business Wire
·
27 Feb

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
05 Feb

Astria Therapeutics' Shares Rise After JMP Securities Initiates Coverage With Outperform Rating

MT Newswires Live
·
01 Feb

Astria Therapeutics Price Target Maintained With a $16.00/Share by HC Wainwright & Co.

Dow Jones
·
24 Jan

Astria Therapeutics Starts Phase 1a Trial of Atopic Dermatitis Treatment

MT Newswires Live
·
23 Jan

Astria initiates Phase 1a Trial of STAR-0310 trial, sees proof of concept in Q3

TIPRANKS
·
23 Jan

Astria Therapeutics Inc - Early Proof-of-Concept Results Expected in Q3 2025

THOMSON REUTERS
·
23 Jan

Astria Therapeutics Announces Initiation of Phase 1a Trial of Star-0310, a Potential Best-in-Class Monoclonal Antibody Ox40 Antagonist for the Treatment of Atopic Dermatitis

THOMSON REUTERS
·
23 Jan

Analysts Offer Insights on Healthcare Companies: Astria Therapeutics (ATXS) and Mediwound (MDWD)

TIPRANKS
·
14 Jan

Astria Therapeutics Announces Design of Alpha-Orbit Pivotal Phase 3 Trial of Navenibart in Hae

THOMSON REUTERS
·
13 Jan

Astria Therapeutics Inc - Phase 3 Initiation Expected in Q1 2025

THOMSON REUTERS
·
13 Jan

Astria Therapeutics Inc: Alpha-Orbit Top-Line Results Anticipated in Early 2027.

THOMSON REUTERS
·
13 Jan

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
04 Jan

Why Rumble Shares Are Trading Higher By Around 43%; Here Are 20 Stocks Moving Premarket

Benzinga
·
23 Dec 2024